vasectomy.
“Non-surgical procedures are always preferred over surgical procedures because they will be safer and less invasive,” said Dr. Anup Kumar, head of urology and renal transplant department, Safdarjung Hospital. “More men are likely to opt for it.”
What’s the Catch?
The drug was developed in India, where the clinical trials also took place, and because of this the manufacture, sale, and distribution of new medical innovation in India requires approval from the Drug Controller General of India (DCGI). This is expected to take about six to seven months.
In addition to the approval timeline, this injection is designed to last approximately 13 years, after which the polymer solution loses its potency. Depending on how you look at it, this is either a bonus or a bust.
“It’s the first in the world from India so we have to be extra careful about approval. We are looking at all aspects, especially the good manufacturing practice (GMP) certification that won’t raise any questions about its quality,” said V.G. Somani, the drug controller general of India.
India is currently at the forefront of male contraception research, but the U.S. is not far behind as researchers have been